Actinium Pharmaceuticals ATNM
NYSE ATNM
$1.17 +0.03 (+2.63%)
As of: Sep 30, 2026 · 2:23 PM EDT

Actinium Pharmaceuticals (ATNM) Net Margin (2021 - 2026)

Updated

Actinium Pharmaceuticals' Net Margin came in at 79.72% for Q2 2026.

Analysis

Actinium Pharmaceuticals (ATNM) Net Margin (2021 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Actinium Pharmaceuticals reported Net Margin of 32.23%; for FY2025, it was -37652.22%.

  • Net Margin carries a four-year change of -35486.66 percentage points (FY2021 to FY2025).
  • Going back by year, Net Margin was -60269.14% in FY2023 (-57063.60 pp), -3205.53% in FY2022 (-1039.97 pp) and -2165.56% in FY2021.
  • The Q2 2026 figure represents the highest quarterly Net Margin in data going back to Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 21.86%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 21.27%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -8.04%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 22.61%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 18.81%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 23.62%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -134.51%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 32.99%
10 Actinium Pharmaceuticals 35.84 Mn 35.84 Mn - 79.72%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 79.72%
Sep 30, 2025 -5,701.11%
Sep 30, 2022 -21,053.33%
Jun 30, 2022 -17,260.00%
Mar 31, 2022 -545.64%
Dec 31, 2021 -34,826.09%
Sep 30, 2021 -2,756.65%
Jun 30, 2021 -1,887.59%
Mar 31, 2021 -855.31%
API Access

Actinium Pharmaceuticals Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=ATNM&period=max&api_key=YOUR_API_KEY